Company Description
Pheton Holdings operates through its PRC operating entity in China, Beijing Feitian, which is a wholly-owned subsidiary of Jinruixi, our wholly foreign-owned enterprise under the PRC law.
Beijing Feitian is a healthcare solution provider dedicated to the development and commercialization of treatment software used for brachytherapy, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.
Beijing Feitian’s proprietary TPS product, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy.
FTTPS is an advanced and user-oriented software for treatment planning of a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect organs at risk and produce a dose distribution plan for brachytherapy for cancer patients.
Beijing Feitian’s operations include the sales of Medical Auxiliary Supplies, such as printed 3D molds, seed implant needles, computer workstations, etc., and the sales of FTTPS-related technical advisories or provisions of consulting services.
| Country | China |
| Founded | 1998 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 10 |
| CEO | Jianfei Zhang |
Contact Details
Address: Room 306, NET Building, Hong Jun Ying South Road Chaoyang District, Beijing China | |
| Phone | (86) 010-8481-7665 |
| Website | ftzy.com.cn |
Stock Details
| Ticker Symbol | PTHL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001970544 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Mr. Jianfei Zhang | Chairman of the Board of Directors and Chief Executive Officer |
| Ms. Zhixin Li | Chief Financial Officer |
| Mr. Pengfei Zhang | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 18, 2024 | POS AM | Post-Effective amendments for registration statement |
| May 3, 2024 | SP 15D2 | Filing |
| May 3, 2024 | POS AM | Post-Effective amendments for registration statement |
| Mar 29, 2024 | EFFECT | Notice of Effectiveness |
| Mar 27, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Mar 1, 2024 | FWP | Free Writing Prospectus |
| Feb 8, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Dec 22, 2023 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Dec 19, 2023 | UPLOAD | Filing |
| Dec 8, 2023 | F-1/A | [Amend] Registration statement for certain foreign private issuers |